Loading...
XNYS
ASIX
Market cap659mUSD
Jun 10, Last price  
24.60USD
1D
0.74%
1Q
3.67%
Jan 2017
11.11%
IPO
28.13%
Name

AdvanSix Inc

Chart & Performance

D1W1MN
P/E
14.94
P/S
0.43
EPS
1.65
Div Yield, %
1.95%
Shrs. gr., 5y
-1.16%
Rev. gr., 5y
3.18%
Revenues
1.52b
-1.05%
1,766,586,0001,790,372,0001,329,409,0001,191,524,0001,475,194,0001,514,984,0001,297,393,0001,157,917,0001,684,625,0001,945,640,0001,533,599,0001,517,557,000
Net income
44m
-19.18%
118,746,00083,858,00063,776,00034,147,000146,699,00066,244,00041,347,00046,077,000139,791,000171,886,00054,623,00044,149,000
CFO
135m
+15.20%
119,995,000188,424,000101,536,000113,740,000134,607,000173,385,000120,385,000111,847,000218,849,000273,601,000117,550,000135,413,000
Dividend
Aug 13, 20240.16 USD/sh
Earnings
Jul 31, 2025

Profile

AdvanSix Inc. manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
IPO date
Sep 14, 2016
Employees
1,458
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,517,557
-1.05%
1,533,599
-21.18%
1,945,640
15.49%
Cost of revenue
1,364,621
1,378,311
1,643,661
Unusual Expense (Income)
NOPBT
152,936
155,288
301,979
NOPBT Margin
10.08%
10.13%
15.52%
Operating Taxes
1,426
14,600
53,905
Tax Rate
0.93%
9.40%
17.85%
NOPAT
151,510
140,688
248,074
Net income
44,149
-19.18%
54,623
-68.22%
171,886
22.96%
Dividends
(17,135)
(16,657)
(15,073)
Dividend yield
2.21%
1.99%
1.37%
Proceeds from repurchase of equity
(9,569)
(45,275)
(32,444)
BB yield
1.23%
5.40%
2.94%
Debt
Debt current
42,493
32,053
37,472
Long-term debt
460,293
329,975
307,614
Deferred revenue
160,409
Other long-term liabilities
11,468
163,904
(149,730)
Net debt
483,222
332,260
314,101
Cash flow
Cash from operating activities
135,413
117,550
273,601
CAPEX
(107,377)
(89,449)
Cash from investing activities
(142,902)
(110,897)
(189,273)
Cash from financing activities
(2,715)
(7,870)
(68,443)
FCF
45,876
100,713
233,628
Balance
Cash
19,564
29,768
30,985
Long term investments
Excess cash
Stockholders' equity
637,841
601,249
563,640
Invested Capital
1,135,011
1,169,155
978,872
ROIC
13.15%
13.10%
26.34%
ROCE
11.95%
13.28%
26.51%
EV
Common stock shares outstanding
27,255
28,008
29,031
Price
28.49
-4.91%
29.96
-21.20%
38.02
-19.53%
Market cap
776,501
-7.46%
839,109
-23.98%
1,103,763
-19.57%
EV
1,259,723
1,171,369
1,417,864
EBITDA
229,112
228,298
371,332
EV/EBITDA
5.50
5.13
3.82
Interest
11,311
7,485
2,781
Interest/NOPBT
7.40%
4.82%
0.92%